Understanding the one-two punch: biomarkers of clinical response to a novel compensatory drug combination for metastatic TNBCRADOVICH, MILANNational Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R21CA229951-02), $199,371USD, 09/14/2018 -- 08/31/2020